| |
(n = 87)
|
|---|
|
Age (years)
|
62.8 ± 13.7
|
|
Sex, male (%)
|
70 (80.5)
|
|
BMI (kg/m2)
|
25.9 ± 4.1
|
|
Systolic BP (mmHg)
|
131.2 ± 11.7
|
|
Diastolic BP (mmHg)
|
79.0 ± 11.2
|
|
CKD duration (months)
|
70.0 ± 47.2
|
|
CKD stage
|
|
Stage 3 (%)
|
45 (51.7)
|
|
Stage 4 (%)
|
38 (43.7)
|
|
Stage 5 (%)
|
3 (3.4)
|
|
Comorbidities (%)
|
|
Hypertension
|
67 (77.0)
|
|
Diabetes
|
41 (48.3)
|
|
Cardiovascular disease
|
13 (14.9)
|
|
Cerebrovascular disease
|
10 (11.5)
|
|
Laboratory data
|
|
Indoxyl sulfate (mg/dL)
|
0.46 ± 0.41
|
|
BUN (mg/dL)
|
35.1 ± 12.7
|
|
Serum creatinine (mg/dL)
|
2.5 ± 0.8
|
|
eGFR (mL/min/1.73m2)
|
31.6 ± 11.3
|
|
Urine PCR (mg/g)
|
3613.4 ± 4203.2
|
|
Hemoglobin (g/dL)
|
12.1 ± 2.0
|
|
Phosphorus (mg/dL)
|
3.6 ± 0.6
|
|
Intact PTH (mg/dL)
|
104.0 ± 101.3
|
|
Uric acid (mg/dL)
|
7.1 ± 1.8
|
|
Albumin (g/dL)
|
3.9 ± 0.6
|
|
Serum Na (mmol/L)
|
139.5 ± 2.5
|
|
Serum K (mmol/L)
|
4.8 ± 0.6
|
|
Total CO2 (mmol/L)
|
23.8 ± 3.3
|
- Data are presented as mean ± standard deviation or number (percentage) of subjects
- Abbreviation: BMI body mass index, BP blood pressure, CKD chronic kidney disease, eGFR estimated glomerular filtration rate, PCR protein to creatinine ratio, PTH parathyroid hormone
